The sold production of basic pharmaceutical products in Sweden showed substantial fluctuations over the past decade. After a period of no recorded production from 2013 to 2016, there was a significant leap in 2017. The market peaked in 2020 with steady growth followed by a sharp decline in 2021. Over the next two years, there was some recovery noted, but the compounded annual growth rate (CAGR) between 2018 and 2023 was negative. The forecast from 2024 suggests a stabilization in the production volume with a modest CAGR of 0.52% over the next five years.

In 2023, the production value stood at 435.78 million Euros.

Future trends to watch for:

Potential impact of new regulatory policies on pharmaceutical production volumes.
Advancements in pharmaceutical technology and biotechnology driving production efficiency.
Shifts in global demand, particularly influenced by health crises or demographic changes.